Nemis Technologies successfully completed a CHF 7.75m Series A financing round with the participation of both institutional and private investors. Nemis will use the investment funds to scale up its production, accelerate the ongoing international
Tags :Francesca Pesenti
Vischer has acted as legal counsel to TargImmune Therapeutics, a private Swiss-based biotechnology firm, on the closing of its 2021 financing round, raising CHF 17.7 million. The Vischer legal team was led by Matthias Staehelin (pictured) with
Vischer acted as legal counsel for Haya Therapeutics, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), on the closing of its CHF 18 million seed round. The financing was led
The team included partner Christian Wyss (Life Sciences - pictured), associate Timothy Woodtli (Corporate/M&A), associate Francesca Pesenti (Corporate/M&A), and associate Gian Geel (Employment).
Helvetia Asset Management launched the real estate fund "Helvetia (CH) Swiss Property Fund" on June 3, 2020.
